Protagonist Therapeutics
NASDAQ: PTGXMilpitas, US · Founded 2006 · Delaware corporation · 162 employees on LinkedIn · 5 known investors
Protagonist is a company that emphasizes a diverse and inclusive corporate culture as central to its innovation, with stated goals of creating wins for its organization and for patients.
Founders & leadership
DV
Dinesh V. Patel, PhDExecutive
DP
Dinesh PatelPresident & Chief Executive Officer
Board
AK
Asish K. Xavier, Ph.D.Board director
MP
Michael Panaccio, Ph.D.Board director
AS
Armen Shanafelt, Ph.D.Board director
PF
Paul F. TruexBoard director
HE
Harold E. Selick, Ph.D.Board director
Investors · 5
Reported raises · per SEC filings
Form D private placements$17.5M disclosed across 1 round · 2015
▶$17.5MraisedJul 2015 · 9 investors · BiotechnologyRule 506(b)
▶$17.5MraisedJul 2015 · 9 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Paul F. TruexDirector
- Asish K. Xavier, Ph.D.Director
- Michael Panaccio, Ph.D.Director
- Armen Shanafelt, Ph.D.Director
- Dinesh V. Patel, PhDExecutive Officer, Director
- Harold E. Selick, Ph.D.Director
- Offering amount
- $40M
- Amount sold
- $17.5M
- First sale
- Jul 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 4
by search overlap
Seeking Alpha32 shared keywordsSeeking Alpha is a financial research platform offering stock analysis, market news, investment ideas, and quantitative ratings across asset classes, drawing on a large community of contributing analysts. It serves individual and professional investors seeking research and data-driven insight on stocks and markets.
Robinhood28 shared keywordsRobinhood is a financial trading platform that enables users to manage portfolios across stocks, ETFs, cryptocurrencies, options, futures, and prediction markets. The platform serves retail investors with low barriers to entry, offering portfolio management services and market insights.
TipRanks27 shared keywordsFinancial analysis and stock research platform.
Thumbnail for Seragon Pharmaceuticals25 shared keywordsGenentech is a biotechnology company that develops and manufactures breakthrough medicines in the United States, backed by a $50 billion commitment to U.S. manufacturing and scientific innovation.
Companies competing with Protagonist Therapeutics for the same Google search keywords, organic and paid, via search-intersection analysis.
Non-dilutive funding · 4 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2018 | $1.5M |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2017 | $1.3M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2016 | $218.8K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2015 | $223.9K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
In the news
Frequently asked questions
- What does Protagonist Therapeutics do?
- Protagonist is a company that emphasizes a diverse and inclusive corporate culture as central to its innovation, with stated goals of creating wins for its organization and for patients.
- Who are Protagonist Therapeutics's investors?
- Protagonist Therapeutics's investors include Aisling Capital, Canaan Partners, JJDC, Lilly Ventures, Starfish Ventures.
- How much funding has Protagonist Therapeutics raised?
- Protagonist Therapeutics has disclosed $17.5M raised across 1 round.
- Where is Protagonist Therapeutics headquartered?
- Protagonist Therapeutics is headquartered in Milpitas, US.